Spots Global Cancer Trial Database for glutathione
Every month we try and update this database with for glutathione cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | NCT00323583 | Adenocarincoma ... Stage III Pancr... Stage IVA Pancr... Stage IVB Pancr... | paclitaxel oxaliplatin leucovorin 5-fluorouracil glutathione calcium and mag... Chemotherapy Chemoprotection Complementary a... | 18 Years - 65 Years | Seattle Cancer Treatment and Wellness Center | |
| Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities | NCT02321579 | Liver Cirrhosis Liver Cancer | vitamin B-6 Glutathione Dextrins | 20 Years - 80 Years | Taichung Veterans General Hospital | |
| Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS) | NCT00700206 | Myelodysplastic... | Ezatiostat Hydr... | 18 Years - | Telik | |
| KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC | NCT04265534 | Non-Small Cell ... Non-squamous No... Non-Squamous No... KEAP1 Gene Muta... NRF2 Gene Mutat... NFE2L2 Gene Mut... | Telaglenastat Carboplatin Che... Pemetrexed Chem... Pembrolizumab I... Placebo Folic acid 400 ... Vitamin B12 100... Dexamethasone 4... | 18 Years - | Calithera Biosciences, Inc | |
| Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome | NCT01459159 | Myelodysplastic... | ezatiostat hydr... | 18 Years - | Telik | |
| KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC | NCT04265534 | Non-Small Cell ... Non-squamous No... Non-Squamous No... KEAP1 Gene Muta... NRF2 Gene Mutat... NFE2L2 Gene Mut... | Telaglenastat Carboplatin Che... Pemetrexed Chem... Pembrolizumab I... Placebo Folic acid 400 ... Vitamin B12 100... Dexamethasone 4... | 18 Years - | Calithera Biosciences, Inc | |
| Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer | NCT02311907 | Chemotherapeuti... Neuropathy Neurotoxicity S... Pain Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... | Carboplatin Glutathione Laboratory Biom... Paclitaxel Placebo Quality-of-Life... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma | NCT01148108 | Mantle Cell Lym... B Cell Lymphoma Multiple Myelom... | Canfosfamide HC... | 18 Years - | Telik | |
| Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS) | NCT00700206 | Myelodysplastic... | Ezatiostat Hydr... | 18 Years - | Telik |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
